This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Brigham and Women's Hospital, Inc., Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2017-2026.
Company Filing History:
2 out of 1,422 
1 out of 1,264 
1 out of 480 
Years Active: 2017-2026
Title: Birgit Knoechel: Innovator in Cancer Therapy
Introduction
Birgit Knoechel is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of cancer therapy, particularly in the diagnosis and treatment of various cancers. With a total of 2 patents, her work focuses on innovative therapeutic strategies that aim to improve patient outcomes.
Latest Patents
Knoechel's latest patents include groundbreaking inventions such as "Targeting Galectin-9 as a Therapeutic Strategy for T-Cell Exhaustion in T-Cell Acute Lymphoblastic Leukemia." This patent addresses critical methods for diagnosing and treating subjects with cancer, especially those characterized by Notch pathway activation mutations or resistance to Notch pathway inhibitors. Her inventions are pivotal in advancing cancer treatment methodologies.
Career Highlights
Throughout her career, Birgit Knoechel has worked with esteemed institutions such as Brigham and Women's Hospital and Dana-Farber Cancer Institute. Her experience in these leading research environments has allowed her to develop and refine her innovative approaches to cancer therapy.
Collaborations
Knoechel has collaborated with notable professionals in her field, including Jon C. Aster and Praveen Anand. These partnerships have further enhanced her research and contributed to the advancement of cancer treatment strategies.
Conclusion
Birgit Knoechel's contributions to cancer therapy through her patents and collaborations highlight her role as a leading innovator in the medical field. Her work continues to inspire advancements in the diagnosis and treatment of cancer, ultimately benefiting patients worldwide.